A Unified Program Integrity Contractor (UPIC) audit of a pain management practice rarely opens as a routine coding review. UPICs are CMS's fraud-focused contractors, and once injection billing, urine drug testing, and controlled substance prescribing appear on the same claims file, the contractor evaluates the pattern across all three, not any single line item. For a physician performing facet joint injections, ordering definitive drug testing, or prescribing Schedule II opioids, the exposure runs from claim-by-claim recoupment to a target letter naming the practice in a wider investigation. Three fact patterns draw the closest scrutiny: injection frequency that outpaces documented relief, definitive testing billed without a supporting presumptive result, and prescribing data a UPIC reads on its own terms.
Why UPICs Read Pain Management Claims Differently
UPICs replaced the legacy ZPIC program and run CMS's fraud-focused review lane, distinct from RAC and MAC contractors, which target payment accuracy rather than intent (see how UPIC audits are structured). CoventBridge and the other current UPIC zone contractors apply data analytics before requesting records, comparing a prescriber's Schedule II through V billing and injection frequency against regional peers. A pain management practice whose injection volume, definitive testing rate, or opioid dosing sits outside that peer band is more likely to receive a document request that arrives already narrowed to a specific procedure code or drug class, rather than a broad records pull.
Injection Frequency Limits Under CMS Facet Joint Policy
Medicare's Local Coverage Determinations for facet joint interventions cap therapeutic facet joint injections at four sessions per covered spinal region in a rolling 12 months, with no more than two radiofrequency ablation sessions in the same period. Repeat therapeutic injections at the same level require documentation of at least 50% pain relief lasting a minimum of three months from the prior procedure, and repeat radiofrequency ablation requires at least 50% relief lasting six months. A chart that bills the maximum allowed sessions without recording the relief percentage and duration, or that repeats a level after a documented non-response, is the single most common defect UPIC reviewers cite in a pain management injection audit.
Urine Drug Testing Billing Under OIG Scrutiny
The HHS Office of Inspector General found that Medicare could have saved up to $215.8 million from 2016 through 2020 on definitive drug testing, because providers who routinely billed code G0483, covering 22 or more drug classes at the highest reimbursement rate, did not consistently rely on a presumptive test result to determine how many classes required definitive confirmation. Definitive testing is medically necessary only when a presumptive result is unexpected and needs confirmation, and billing both tests on the same specimen without that clinical trigger is a pattern OIG has flagged directly.
Where Controlled Substance Prescribing Overlaps the Audit
A UPIC audit of injection and testing claims does not stop at billing. Under 21 CFR 1306.04, a controlled substance prescription is valid only when issued for a legitimate medical purpose in the usual course of professional practice, and a prescriber who cannot document that purpose faces exposure beyond recoupment. When an auditor's data review surfaces opioid and benzodiazepine co-prescribing, escalating morphine milligram equivalents, or injection and prescribing patterns concentrated in a single referral source, the matter can move from a civil audit finding to a target letter and a parallel DEA registration action.
A single UPIC document request commonly asks a pain management practice to produce injection frequency logs, urine drug testing orders, and controlled substance prescribing records together, because the contractor is weighing the pattern across all three, not one billing line in isolation.
Why Early Legal Counsel Is Critical
It is critical that pain management practices and the physicians who order injections, drug testing, and controlled substance prescriptions promptly retain experienced healthcare defense counsel upon receiving a UPIC records request, subpoena, or other government inquiry. Early legal intervention can protect the practice's rights, ensure appropriate responses to government requests, avoid inadvertent admissions, preserve relevant defenses, and allow counsel to communicate with investigators on the practice's behalf. Delaying legal representation can significantly affect the outcome of a matter and expose the practice to unnecessary risk.
How Health Law Alliance Can Help
Health Law Alliance defends pain management practices and the physicians who order their injections, drug testing, and controlled substance prescriptions against UPIC audits nationwide, with 2,000+ audits overseen across the bench. If your practice has received a UPIC records request or a physician on staff has been contacted directly, contact our UPIC audit defense team for a free, confidential consultation before you respond.
